Targeting survivin (BIRC5) with YM155 for the treatment of head and neck squamous cell carcinoma

被引：0
|
作者：
Kumar, Bhavna [1 ]
Yadav, Arti [1 ]
Teknos, Theodoros N. [1 ]
Kumar, Pawan [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5604
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Survivin Inhibitor YM155 Induces Apoptosis and Inhibits Tumor Growth of Human Gastric Carcinoma
    Cheng, Xiaojiao
    Ding, Yanfei
    Zhu, Liming
    Qiao, MInmin
    Ye, Jing
    Jiang, Shihu R.
    Tu, Shuiping
    GASTROENTEROLOGY, 2013, 144 (05) : S168 - S168
  • [32] miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
    Chao Yuan
    Zhenhong Su
    Shengjie Liao
    Duanzhuo Li
    Zhiwen Zhou
    Yawen Wang
    Mingchun Quan
    Lingling Zeng
    Cai Lv
    Chenyi Shen
    Weida Gong
    Jianfeng Wu
    Xiaogang Chen
    Wenbing Hu
    Xu Lv
    Wenxia Si
    Xin Yu
    Cancer Cell International, 21
  • [33] Functional Characterization of Novel Mutations Affecting Survivin (BIRC5)-Mediated Therapy Resistance in Head and Neck Cancer Patients
    Knauer, Shirley K.
    Unruhe, Britta
    Karczewski, Sarah
    Hecht, Rouven
    Fetz, Verena
    Bier, Carolin
    Friedl, Sandra
    Wollenberg, Barbara
    Pries, Ralph
    Habtemichael, Negusse
    Heinrich, Ulf-Ruediger
    Stauber, Roland H.
    HUMAN MUTATION, 2013, 34 (02) : 395 - 404
  • [34] Sebaceous gland carcinoma of the eyelid: Prognostic significance of nuclear survivin (BIRC5)
    Mulay, K.
    White, V.
    Shah, S.
    Honavar, S.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 117 - 117
  • [35] OVER-EXPRESSION OF SURVIVIN ENHANCES THE CHEMOTHERAPEUTIC EFFECTIVENESS OF YM155 IN HUMAN HEPATOCELLULAR CARCINOMA
    Xia, H.
    Chen, J.
    Shi, M.
    Deivasigamani, A.
    Ooi, L. L.
    Hui, K. M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S392 - S392
  • [36] miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
    Yuan, Chao
    Su, Zhenhong
    Liao, Shengjie
    Li, Duanzhuo
    Zhou, Zhiwen
    Wang, Yawen
    Quan, Mingchun
    Zeng, Lingling
    Lv, Cai
    Shen, Chenyi
    Gong, Weida
    Wu, Jianfeng
    Chen, Xiaogang
    Hu, Wenbing
    Lv, Xu
    Si, Wenxia
    Yu, Xin
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [37] Targeting Survivin with YM155 (Sepantronium Bromide): A novel therapeutic strategy for paediatric acute myeloid leukaemia
    Smith, Amanda M.
    Little, Erica B.
    Zivanovic, Andjelija
    Hong, Priscilla
    Liu, Alfred K. S.
    Burow, Rachel
    Stinson, Caedyn
    Hallahan, Andrew R.
    Moore, Andrew S.
    LEUKEMIA RESEARCH, 2015, 39 (04) : 435 - 444
  • [38] The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma
    Xia, Hongping
    Chen, Jianxiang
    Shi, Ming
    Deivasigamani, Amudha
    Ooi, London Lucien P. J.
    Hui, Kam M.
    ONCOTARGET, 2015, 6 (08) : 5990 - 6000
  • [39] Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin
    Wang, Xu
    Beitler, Jonathan J.
    Huang, Wen
    Chen, Guo
    Qian, Guoqing
    Magliocca, Kelly
    Patel, Mihir R.
    Chen, Amy Y.
    Zhang, Jun
    Nannapaneni, Sreenivas
    Kim, Sungjin
    Chen, Zhengjia
    Deng, Xingming
    Saba, Nabil F.
    Chen, Zhuo Georgia
    Arbiser, Jack L.
    Shin, Dong M.
    CLINICAL CANCER RESEARCH, 2018, 24 (04) : 858 - 869
  • [40] Prognostic Significance of the BIRC2-BIRC3 Gene Signature in Head and Neck Squamous Cell Carcinoma
    Lee, Min Kyeong
    Noh, Joo Kyung
    Woo, Seon Rang
    Kong, Moonkyoo
    Lee, Young Chan
    Lee, Jung Woo
    Ko, Seong-Gyu
    Eun, Young-Gyu
    CANCER GENOMICS & PROTEOMICS, 2022, 19 (05) : 591 - 605
12345